![J. Carroll](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
J. Carroll
Président chez
ESPERION THERAPEUTICS, INC.
Fortune : 555 647 $ au 31/05/2026
Profil
J.
Martin Carroll is Chairman at Esperion Therapeutics, Inc. since 2022.
Mr. Carroll is Lead Director at Catalent Pharma Solutions, Inc. since 2021.
Former roles include President & Chief Executive Officer at Boehringer Ingelheim Pharmaceuticals, Inc. from 2003 to 2011; Chairman at Inotek Pharmaceuticals Corp.
from 2016 to 2018; Independent Director at VIVUS, Inc. from 2013 to 2014; Director at Accredo Health, Inc. from 2004 to 2005; Independent Director at Keenova Therapeutics Plc from 2013 to 2022; Director at Boehringer Ingelheim Corp.
from 2011 to 2012; Director at Pharmaceutical Research & Manufacturers of America; Director at Durata Therapeutics, Inc. in 2014; Independent Director at TherapeuticsMD, Inc. from 2015 to 2021; Independent Director at Catalent, Inc. from 2023 to 2024; Executive VP-Customer Marketing & Sales at Merck & Co., Inc. from 1976 to 2001; Global Head-Strategy & Development at Boehringer Ingelheim GmbH from 2012 to 2013; Trustee at Gwynedd-Mercy College.
Education includes an MBA from Babson College and undergraduate studies at Holy Cross College (Indiana).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/05/2026 | 177 523 ( 0,07 % ) | 555 647 $ | 31/05/2026 |
Postes actifs de J. Carroll
| Sociétés | Poste | Début |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Président | 01/06/2022 |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Directeur/Membre du Conseil | 01/07/2015 |
Anciens postes connus de J. Carroll
| Sociétés | Poste | Fin |
|---|---|---|
| CATALENT, INC. | Président | 29/08/2023 |
| MALLINCKRODT PLC | Directeur/Membre du Conseil | 16/06/2022 |
| THERAPEUTICSMD, INC. | Directeur/Membre du Conseil | 31/12/2021 |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Président | 01/01/2018 |
| DURATA THERAPEUTICS INC | Directeur/Membre du Conseil | 17/11/2014 |
Formation de J. Carroll
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies | Health Technology |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Manufactures and wholesales animal health & pharmaceutical products | Health Technology |
Accredo Health, Inc.
 Accredo Health, Inc. Services to the Health IndustryHealth Services Provides retail pharmacy services | Health Services |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gwynedd-Mercy College
 Gwynedd-Mercy College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
Holy Cross College (Indiana)
 Holy Cross College (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
TherapeuticsMD, Inc.
 TherapeuticsMD, Inc. Pharmaceuticals: MajorHealth Technology Manufactures women’s healthcare products | Health Technology |
Catalent, Inc.
 Catalent, Inc. Pharmaceuticals: MajorHealth Technology Provides delivery technologies and development solutions | Health Technology |
